Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Engelhart

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Mbio|June 23, 2023
Metabolically distinct roles of NAD synthetase and NAD kinase define the essentiality of NAD and NADP in <i>Mycobacterium tuberculosis</i>Ritu Sharma, Travis E Hartman, Tiago Beites, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2025
Microbiological evidence for the trisubstituted benzimidazoles targeting MmpL3 in <i>Mycobacterium tuberculosis</i>Mengyun Zhang, Renee Allen, Lauren Ames, et al.
Cell|July 23, 2021
Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosisBarbara Bosch, Michael A DeJesus, Nicholas C Poulton, et al.
Journal of Medicinal Chemistry|April 22, 2026
Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in <i>Mycobacterium tuberculosis</i>Qiang Liu, Curtis A Engelhart, Joshua B Wallach, et al.
Science Translational Medicine|April 27, 2018
Targeting protein biotinylation enhances tuberculosis chemotherapyDivya Tiwari, Sae Woong Park, Maram M Essawy, et al.
Chemical Science|May 2, 2025
Tailored phenyl ureas eradicate drug-resistant <i>Mycobacterium tuberculosis</i> by targeting mycolic acid cell wall assemblyDietrich Mostert, Josef Braun, Matthew D Zimmerman, et al.
Nature Microbiology|May 31, 2022
CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosisShuqi Li, Nicholas C Poulton, Jesseon S Chang, et al.
Journal of Medicinal Chemistry|October 24, 2018
Discovery and Structure-Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2'-OxidaseSangmi Oh, Yumi Park, Curtis A Engelhart, et al.
Journal of Medicinal Chemistry|January 17, 2025
Metabolically Stable Adenylation Inhibitors of Biotin Protein Ligase as Antibacterial AgentsQiang Liu, Curtis A Engelhart, Joshua B Wallach, et al.
Nature Communications|November 2, 2019
Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug developmentTiago Beites, Kathryn O'Brien, Divya Tiwari, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Mbio|June 23, 2023
Metabolically distinct roles of NAD synthetase and NAD kinase define the essentiality of NAD and NADP in <i>Mycobacterium tuberculosis</i>Ritu Sharma, Travis E Hartman, Tiago Beites, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2025
Microbiological evidence for the trisubstituted benzimidazoles targeting MmpL3 in <i>Mycobacterium tuberculosis</i>Mengyun Zhang, Renee Allen, Lauren Ames, et al.
Cell|July 23, 2021
Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosisBarbara Bosch, Michael A DeJesus, Nicholas C Poulton, et al.
Journal of Medicinal Chemistry|April 22, 2026
Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in <i>Mycobacterium tuberculosis</i>Qiang Liu, Curtis A Engelhart, Joshua B Wallach, et al.
Science Translational Medicine|April 27, 2018
Targeting protein biotinylation enhances tuberculosis chemotherapyDivya Tiwari, Sae Woong Park, Maram M Essawy, et al.
Chemical Science|May 2, 2025
Tailored phenyl ureas eradicate drug-resistant <i>Mycobacterium tuberculosis</i> by targeting mycolic acid cell wall assemblyDietrich Mostert, Josef Braun, Matthew D Zimmerman, et al.
Nature Microbiology|May 31, 2022
CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosisShuqi Li, Nicholas C Poulton, Jesseon S Chang, et al.
Journal of Medicinal Chemistry|October 24, 2018
Discovery and Structure-Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2'-OxidaseSangmi Oh, Yumi Park, Curtis A Engelhart, et al.
Journal of Medicinal Chemistry|January 17, 2025
Metabolically Stable Adenylation Inhibitors of Biotin Protein Ligase as Antibacterial AgentsQiang Liu, Curtis A Engelhart, Joshua B Wallach, et al.
Nature Communications|November 2, 2019
Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug developmentTiago Beites, Kathryn O'Brien, Divya Tiwari, et al.
Pageof 6